AGILE THERAPEUTICS INC (AGRX)
US00847L3087 - Common Stock
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 8.24M | -25.41M | -74.89M | -51.85M | -18.61M | |||
| Depreciation Amortization | 380.00K | 1.53M | 2.22M | 280.00K | 160.00K | |||
| Change In Working Capital | 9.37M | -2.13M | -2.85M | 110.00K | 990.00K | |||
| Interest Paid | 360.00K | 1.16M | 2.38M | 2.10M | 0.00 | |||
| Taxes Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Other non cash items | -29.30M | -9.94M | 10.32M | 4.16M | 1.76M | |||
| OPERATING CASH FLOW | -11.31M | -35.95M | -65.20M | -47.31M | -15.69M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | -130.00K | -270.00K | -350.00K | -100.00K | |||
| Other Investing Activity | N/A | 0.00 | 39.73M | -40.34M | N/A | |||
| INVESTING CASH FLOW | 0.00 | -130.00K | 39.46M | -40.69M | -100.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.09M | -17.38M | 0.00 | 20.00M | 0.00 | |||
| Stock Issued/Repurchased | 9.12M | 39.56M | 30.42M | 49.04M | 42.42M | |||
| Other Financing Activity | N/A | N/A | 0.00 | -1.06M | N/A | |||
| FINANCING CASH FLOW | 8.04M | 22.18M | 30.42M | 67.99M | 42.42M | |||
| CHANGE IN CASH | -3.27M | -13.90M | 4.68M | -20.01M | 26.63M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -11.31M | -35.95M | -65.20M | -47.31M | -15.69M | |||
| Capital Expenditure | 0.00 | -130.00K | -270.00K | -350.00K | -100.00K | |||
| FREE CASH FLOW | -11.31M | -36.08M | -65.47M | -47.66M | -15.79M | |||
All data in USD